Search

Your search keyword '"Forestieri, Valeria"' showing total 29 results

Search Constraints

Start Over You searched for: Author "Forestieri, Valeria" Remove constraint Author: "Forestieri, Valeria" Publication Year Range Last 10 years Remove constraint Publication Year Range: Last 10 years
29 results on '"Forestieri, Valeria"'

Search Results

1. Real-life efficacy and safety of cemiplimab in advanced cervical cancer from a nominal use program in Italy: The MITO 44 study

2. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

5. Carboplatin and paclitaxel plus avelumab compared with carboplatin and paclitaxel in advanced or recurrent endometrial cancer (MITO END-3): a multicentre, open-label, randomised, controlled, phase 2 trial

6. Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

7. Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial

8. Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer

10. Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie

11. Eribulin in combination with bevacizumab as second-line treatment for HER2–negative metastatic breast cancer progressing after first-line therapy with paclitaxel and bevacizumab: a multicenter, phase II, single arm trial (GIM11-BERGI)

12. Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational study

13. Palbociclib added to ongoing endocrine therapy for hormone receptor‑positive HER2‑negative metastatic breast cancer: A case report series

14. Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

15. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

16. It is no longer the time to disregard thyroid metastases from breast cancer: a case report and review of the literature

17. Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study

19. Insight on the Role of Leptin: A Bridge from Obesity to Breast Cancer

20. Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie

21. Adjuvant zoledronic acid and letrozole plus ovarian function suppression in premenopausal breast cancer: HOBOE phase 3 randomised trial

22. Adjuvant anastrozole versus exemestane versus letrozole, upfront or after 2 years of tamoxifen, in endocrine-sensitive breast cancer (FATA-GIM3): a randomised, phase 3 trial

23. Metabolic and anthropometric changes in early breast cancer patients receiving adjuvant therapy

24. Combined effect of obesity and diabetes on early breast cancer outcome: a prospective observational study

25. Pretreatment Serum Concentration of Vitamin D and Breast Cancer Characteristics: A Prospective Observational Mediterranean Study

26. Long-term survival and BRCA status in male breast cancer: a retrospective single-center analysis

27. Body weight and risk of molecular breast cancer subtypes among postmenopausal Mediterranean women

28. Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial

29. Core curriculum. Oncologia clinica

Catalog

Books, media, physical & digital resources